Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

850755

	registered interest
	date	27/02/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Health Services: Technology
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, whether he has made an assessment of the potential merits of e-health technology in reducing patient waiting lists; and if he will make a statement.
	tabling member constituency	Windsor
	tabling member printed	Adam Afriyie
	uin	129991
	answer	answer is ministerial correction date of answer 07/03/2018 answer text <p>NHS Improvement and NHS England have active programmes of work to review the role of e-health technology in areas such as productivity of operating theatres, the automated monitoring of admitted patients and associated bed occupancy levels and the role of digital patient services.</p><p>Additionally, the e-Referrals Service allows commissioners and acute hospital providers in England to manage their demand and capacity more effectively, providing opportunities for reduced waiting lists. It also enables general practitioners and patients to make informed decisions about the choice of provider for treatment by identifying providers associated with longer waiting times.</p> answering member constituency North East Cambridgeshire answering member printed Stephen Barclay question first answered 07/03/2018 10:50:08 answering member 4095 label Biography information for Steve Barclay
	tabling member	1586 label Biography information for Adam Afriyie

1186530

	registered interest
	date	19/03/2020
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Health Services: Technology
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, whether the National Institute for Health and Care Excellence plans to publish the full outputs of the task and finish groups engaged in the development of its health technology evaluation review.
	tabling member constituency	Reigate
	tabling member printed	Crispin Blunt
	uin	32037
	answer	answer is ministerial correction date of answer 27/04/2020 answer text <p>The National Institute for Health and Care Excellence has advised that it is considering the most appropriate way to publish the relevant information supporting the methods review work. Details will be released in due course.</p> answering member constituency Bury St Edmunds answering member printed Jo Churchill question first answered 27/04/2020 13:47:10 answering member 4380 label Biography information for Jo Churchill
	tabling member	104 label Biography information for Crispin Blunt

1186531

	registered interest
	date	19/03/2020
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Health Services: Technology
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, if he will make an assessment of the implications for his policies on (a) improving access to innovative medicines and (b) fostering the life sciences sector of the National Institute for Health and Care Excellence health technology evaluation review.
	tabling member constituency	Reigate
	tabling member printed	Crispin Blunt
	uin	32038
	answer	answer is ministerial correction date of answer 29/05/2020 answer text <p>The National Institute for Health and Care Excellence (NICE) is reviewing its methods for the development of technology appraisal and highly specialised technology recommendations in line with the commitment in the 2019 voluntary scheme for branded medicines pricing and access. The scheme also states the Government’s expectations for the review as follows: ‘“The Department expects that any future changes to NICE methods and processes would respond to the new types of innovation coming to the market, be consistent with improving the health gain achieved by spending on new innovative medicines, and support faster adoption of the most clinically and cost effective medicines.”’</p><p> </p><p><strong> </strong></p><p><strong> </strong></p> answering member constituency Bury St Edmunds answering member printed Jo Churchill grouped question UIN 32039 question first answered 29/05/2020 16:49:06 answering member 4380 label Biography information for Jo Churchill
	tabling member	104 label Biography information for Crispin Blunt

1699132

	registered interest
	date	26/03/2024
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Health Services: Technology
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, whether she has received representations of concern from (a) patient safety groups and (b) medical equipment suppliers on the interim methods and processes statement for late-stage assessments published by NICE.
	tabling member constituency	St Albans
	tabling member printed	Daisy Cooper
	uin	20775
	answer	answer is ministerial correction date of answer 15/04/2024 answer text <p>The National Institute for Health and Care Excellence’s (NICE) interim methods and processes for late-stage assessment have been subject to a public consultation between 29 February and 28 March 2024. The consultation allowed stakeholders from across the sector, including medical equipment suppliers, patients, and caregivers, to comment on these interim methods and processes. This included the proposed use of predetermined price ranges for categories of technologies. The Department and the NICE are unable to comment on the results of the consultation at this stage, as the NICE is currently considering the responses. Further information will be made available upon the completion of this process.</p> answering member constituency Pendle answering member printed Andrew Stephenson grouped question UIN 20777 question first answered 15/04/2024 08:43:00 answering member 4044 label Biography information for Andrew Stephenson
	tabling member	4769 label Biography information for Daisy Cooper

1699133

	registered interest
	date	26/03/2024
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Health Services: Technology
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, whether her Department has had discussions with NICE on the development of the interim methods and processes statement for late-stage assessment.
	tabling member constituency	St Albans
	tabling member printed	Daisy Cooper
	uin	20776
	answer	answer is ministerial correction date of answer 15/04/2024 answer text <p>The National Institute for Health and Care Excellence (NICE) consulted the Department on the interim methods and processes statement. As stated in paragraph 4.1 of the interim methods and processes, the NICE worked in collaboration with the Department to determine the eight planned assessment topics.</p> answering member constituency Pendle answering member printed Andrew Stephenson question first answered 15/04/2024 08:47:05 answering member 4044 label Biography information for Andrew Stephenson
	tabling member	4769 label Biography information for Daisy Cooper

1699134

	registered interest
	date	26/03/2024
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Health Services: Technology
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, whether she has made an assessment of the potential (a) risks and (b) benefits to (i) patients and (ii) caregivers of the use of a predetermined price range for categories of technologies in the new late-stage assessment process adopted by NICE.
	tabling member constituency	St Albans
	tabling member printed	Daisy Cooper
	uin	20777
	answer	answer is ministerial correction date of answer 15/04/2024 answer text <p>The National Institute for Health and Care Excellence’s (NICE) interim methods and processes for late-stage assessment have been subject to a public consultation between 29 February and 28 March 2024. The consultation allowed stakeholders from across the sector, including medical equipment suppliers, patients, and caregivers, to comment on these interim methods and processes. This included the proposed use of predetermined price ranges for categories of technologies. The Department and the NICE are unable to comment on the results of the consultation at this stage, as the NICE is currently considering the responses. Further information will be made available upon the completion of this process.</p> answering member constituency Pendle answering member printed Andrew Stephenson grouped question UIN 20775 question first answered 15/04/2024 08:43:00 answering member 4044 label Biography information for Andrew Stephenson
	tabling member	4769 label Biography information for Daisy Cooper

1139441

	registered interest
	date	16/07/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Health Services: Technology
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, with reference to item 9 of NICE’s public board meeting agenda, 17 July 2019, how will membership of the (a) task and finish groups and (b) patient working group be decided; and what opportunities will exist for patient groups not invited to participate with the patient working group.
	tabling member constituency	Cambridge
	tabling member printed	Daniel Zeichner
	uin	277756
	answer	answer is ministerial correction date of answer 22/07/2019 answer text <p>The National Institute for Health and Care Excellence (NICE) has advised that membership of the task and finish groups will be decided by the working group. There are three patient/lay representatives on the methods working group with a wide range of experience, covering a range of topic areas, reflecting the programmes under review. Two of the patient/lay representatives also belong to the Patients Involved in NICE coalition.</p><p>NICE has established a dedicated patient working group. There are six patient organisation representatives on the group, including those who belong to the Patients Involved in NICE coalition. The group will work directly with patient/carer groups to coordinate the patient perspective on both methods and process.</p><p>A stakeholder workshop with patient groups was held in January 2019 that included representatives from 22 patient organisations.</p><p>Patient groups will be involved in the review of each of the specific methodological areas as detailed in the paper presented to the NICE board on 17 July 2019. Experts in the area will be invited to participate in topic specific methods task and finish groups.</p><p>Patient organisations will have the opportunity to comment directly on proposals during the public consultation in summer 2020.</p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 22/07/2019 14:24:22 answering member 4455 label Biography information for Seema Kennedy
	tabling member	4382 label Biography information for Daniel Zeichner

1627261

	registered interest
	date	12/05/2023
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Health Services: Technology
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, whether he has had recent discussions with (a) National Institute for Health and Care (NICE), (b) NHS England and (c) other system partners on the potential merits of lowering the discount rate applied to technologies with health gains evaluated by NICE.
	tabling member constituency	Strangford
	tabling member printed	Jim Shannon
	uin	184823
	answer	answer is ministerial correction date of answer 17/05/2023 answer text <p>Department officials regularly discuss a range of issues with colleagues in the National Institute for Health and Care Excellence (NICE) and NHS England, including related to aspects of NICE’s methods for health technology evaluation.</p> answering member constituency Colchester answering member printed Will Quince question first answered 17/05/2023 15:49:07 answering member 4423 label Biography information for Will Quince
	tabling member	4131 label Biography information for Jim Shannon

1059725

	registered interest
	date	12/02/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Health Services: Technology
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, with reference to the NHS Long Term Plan, what steps his Department is taking to improve the rate of adoption of ready for speed health technology products.
	tabling member constituency	Leicester South
	tabling member printed	Jonathan Ashworth
	uin	220224
	answer	answer is ministerial correction date of answer 20/02/2019 answer text <p>The NHS Long Term Plan and the second Life Sciences Sector Deal set out the Government and National Health Service commitment to ensuring that patients are able to receive the best treatments as fast as possible.</p><p> </p><p>From 2020, a new NHS England health tech funding requirement will identify the best value innovations as ‘ready to spread’ and help the NHS to adopt them quickly. This will apply to health tech products which have been assessed as cost saving by the National Institute for Health and Care Excellence (NICE). In addition, NICE will significantly increase the number of evaluations it does for health tech products, so that the NHS has the evidence it needs to decide the best products to adopt and spread.</p><p> </p><p>Improving the adoption and spread of high quality innovations is also a priority for the Accelerated Access Collaborative under the leadership of Lord Darzi. In October, they identified 12 products that should be supported for rapid spread across the NHS, and further products will be identified this year. The Academic Health Science Networks are also a key partner in supporting the adoption and spread of health tech across the system, and the NHS Long Term Plan commits to their continued role in improving access to innovation.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 20/02/2019 17:32:16 answering member 4067 label Biography information for Steve Brine
	tabling member	4244 label Biography information for Jonathan Ashworth

227305

	registered interest
	date	13/03/2015
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Health Services: Technology
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, what technologies are being developed with support from the Small Business Research Initiative programmes of (a) his Department and (b) NHS England; and what assessment he has made of the future potential uses of those technologies.
	tabling member constituency	Streatham
	tabling member printed	Mr Chuka Umunna
	uin	227523
	answer	answer is ministerial correction date of answer 20/03/2015 answer text <p>The Department, through the Small Business Research Initiative (SBRI), is currently funding the development of a number of technologies aimed at promoting patient empowerment and sustainability in kidney care. Six phase 2 SBRI contracts valued at £2 million were awarded in February 2015. The technologies being developed range from diagnostics to digital solutions, for use in the home and in secondary care. Potential uses include early infection detection in patients on peritoneal dialysis, prevention of acute kidney injury and renal patient transport.</p><p> </p><p> </p><p> </p><p>The Department is also supporting, through SBRI, the development of enabling technologies for genomics sequence data analysis and interpretation. In March 2015 five phase 2 SBRI contracts, valued at £8 million, were awarded for the development of next generation sequencing technologies which were assessed as having the potential to help deliver the Prime Minister’s 100,000 Genome Project. Potential uses are in the areas of diagnostics related to genome screening, clinical research, gene-discovery and wider use of stratified medicine. The technologies are hoped to provide more accurate variant calling and annotation pipelines, new ways of expressing the reference genomes, improving human leukocyte antigen genotyping and intuitive user interfaces to allow clinicians to interpret variants from next generation sequencing machines.</p><p> </p><p> </p><p> </p><p>The NHS England SBRI Healthcare programme currently has 138 contracts with companies to develop innovative technologies to address known healthcare needs. These range from diagnostics to digital management solutions; embracing conditions such as cancer, chronic obstructive pulmonary disease, cardiovascular disease, diabetes, dementia and patient safety and bringing solutions for mental health, primary and acute care. Assessment of the programme by the Office of Health Economics and the SBRI Healthcare team in 2014 has shown that since 2012 the pipeline has a potential to secure £434 million efficiency savings each year for the next decade. Assessment of the programme also shows that 150 jobs have been created, 31 patents awarded and over £10 million of additional investment has been leveraged.</p><p> </p><p> </p><p> </p><p>The technologies supported include a light therapy sleep mask for the prevention of diabetic retinopathy; ultraviolet scope enabling intraoperative visibility of cancer cells in surgery; a point of care cardiac diagnostic to fully diagnose a heart attack within 20 minutes and a blood test to definitively rule out a diagnosis of colorectal cancer.</p><p> </p> answering member constituency Battersea answering member printed Jane Ellison question first answered 20/03/2015 14:35:19 answering member 3918 label Biography information for Jane Ellison
	tabling member	4128 label Biography information for Chuka Umunna